An HIV/AIDS Prophylactic vaccine is possible.

Zhong Q, Luftig RB.

J Immune Based Ther Vaccines. 2007 Dec 19;5:12.

PMID: 18093321 [PubMed - in process]

Related Articles Free article in PMC

Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.

Hammond SA, Bollinger RC, Stanhope PE, Quinn TC, Schwartz D, Clements ML, Siliciano RF.

J Exp Med. 1992 Dec 1;176(6):1531-42.

PMID: 1460417 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Becker Y.

Virus Genes. 1994 Jul;8(3):249-70. Review.

PMID: 7975271 [PubMed - indexed for MEDLINE]

Related Articles

The hunt for the AIDS vaccine.

Essex M.

AIDS Asia. 1995 May-Jun;2(3):10-3.

PMID: 12319586 [PubMed - indexed for MEDLINE]

Related Articles

Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.

Valenzuela A, Blanco J, Krust B, Franco R, Hovanessian AG.

J Virol. 1997 Nov;71(11):8289-98.

PMID: 9343181 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

Belshe RB, Gorse GJ, Mulligan MJ, Evans TG, Keefer MC, Excler JL, Duliege AM, Tartaglia J, Cox WI, McNamara J, Hwang KL, Bradney A, Montefiori D, Weinhold KJ.

AIDS. 1998 Dec 24;12(18):2407-15.

PMID: 9875578 [PubMed - indexed for MEDLINE]

Related Articles

HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.

Adis International Ltd.

Drugs R D. 2003;4(4):249-53.

PMID: 12848591 [PubMed - indexed for MEDLINE]

Related Articles

Post-infection immunodeficiency virus control by neutralizing antibodies.

Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T.

PLoS ONE. 2007 Jun 20;2(6):e540.

PMID: 17579714 [PubMed]

Related Articles Free article in PMC

[Deep lung--cellular reaction to HIV]

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID: 17492233 [PubMed - indexed for MEDLINE]

Related Articles

Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.

Golding B, Inman J, Highet P, Blackburn R, Manischewitz J, Blyveis N, Angus RD, Golding H.

J Virol. 1995 Jun;69(6):3299-307.

PMID: 7745677 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.

Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H.

J Virol. 1996 May;70(5):3084-92.

PMID: 8627787 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL.

J Immunol. 2002 Jan 15;168(2):562-8.

PMID: 11777947 [PubMed - indexed for MEDLINE]

Related Articles

Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Becker Y.

Virus Genes. 2006 Oct;33(2):235-52. Review.

PMID: 16972040 [PubMed - indexed for MEDLINE]

Related Articles

CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.

Becker Y.

Virus Genes. 2005 Mar;30(2):251-66. Review.

PMID: 15744581 [PubMed - indexed for MEDLINE]

Related Articles

Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques.

Kent SJ, Ada GL, Hayes E, Lewis IM.

Immunol Rev. 2001 Oct;183:94-108. Review.

PMID: 11782250 [PubMed - indexed for MEDLINE]

Related Articles

Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.

Finnegan CM, Berg W, Lewis GK, DeVico AL.

J Virol. 2001 Nov;75(22):11096-105.

PMID: 11602749 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.

Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.

J Virol. 2005 Aug;79(15):9872-84.

PMID: 16014948 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.

Kelly HR, Urbanski M, Burda S, Zhong P, Konings F, Nanfack J, Tongo M, Kinge T, Achkar J, Nyambi P.

Hum Antibodies. 2005;14(3-4):89-99.

PMID: 16720979 [PubMed - indexed for MEDLINE]

Related Articles

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID: 12563091 [PubMed - indexed for MEDLINE]

Related Articles

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

Epstein JE, Charoenvit Y, Kester KE, Wang R, Newcomer R, Fitzpatrick S, Richie TL, Tornieporth N, Heppner DG, Ockenhouse C, Majam V, Holland C, Abot E, Ganeshan H, Berzins M, Jones T, Freydberg CN, Ng J, Norman J, Carucci DJ, Cohen J, Hoffman SL.

Vaccine. 2004 Apr 16;22(13-14):1592-603.

PMID: 15068840 [PubMed - indexed for MEDLINE]

Related Articles